PAR Pharmaceutical Companies, INC.
SEC CIK 878088 · prx · last insider filing 2012-10-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Lepore Patrick G | Director · Executive Chairman | filed 2006 - 2012 |
| Zenner Patrick J | Director | filed 2010 - 2012 |
| Sharoky Melvin MD | Director | filed 2007 - 2012 |
| Nordmann Ronald M | Director | filed 2006 - 2012 |
| Knight Peter S | Director | filed 2006 - 2012 |
| Smith Joseph E | Director | filed 2006 - 2012 |
| Rice Thomas P | Director | filed 2009 - 2012 |
| Haughey Thomas | Director · VP, General Counsel, Secy | filed 2006 - 2012 |
| Campanelli Paul | Director · Exec VP; Pres-Generic Div | filed 2007 - 2012 |
| Abernathy John D | Director | filed 2006 - 2010 |
| Seidman L William | Director | filed 2006 - 2009 |
| Williams Peter | Director | filed 2006 - 2007 |
| Auerbach Mark | Director · Executive Chairman | filed 2006 - 2006 |
| Tarriff Scott L | Director · President & CEO | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Tropiano Michael A | Executive Vice President & CFO | filed 2010 - 2012 |
| Macphee John A | Pres. Branded Products Div | filed 2006 - 2011 |
| Kenyon Lawrence A | EVP, Chief Financial Officer | filed 2008 - 2010 |
| Martino Gerard | Vice President & CFO | filed 2006 - 2009 |
| Lubatkin Veronica | Executive Vice Pres & CFO | filed 2007 - 2009 |
| O Connor Dennis J | Vice President, CFO | filed 2006 - 2006 |
| Hariharan Shankar | VP, Chief Scientific Officer | filed 2006 - 2006 |
| Graves Michael | Pres, Generic Products Div | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.